ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,765.04
-0.47%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Adhera Therapeutics Inc (PK) (ATRX)

  7. Adhera Therapeutics Inc (PK) (ATRX) ニュース

ATRX

Adhera Therapeutics (PK) (ATRX)

Adhera Therapeutics Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:ATRX
日付受信時刻ニュースソース見出しコード企業名
2024/01/3106 : 00Edgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERUSOTC:ATRXAdhera Therapeutics Inc (PK)
2024/01/1906 : 25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
2024/01/1706 : 01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
2023/11/3006 : 01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
2023/11/2106 : 51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/11/1606 : 35Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (PK)
2023/10/1305 : 58Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
2023/08/2204 : 32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/08/1605 : 05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (PK)
2023/06/3005 : 54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
2023/05/2304 : 14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/05/0605 : 03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/05/0505 : 07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/04/0104 : 17Edgar (US Regulatory)Annual Report (10-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/03/0906 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/02/2407 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2023/01/2706 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/12/0307 : 08Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/11/2303 : 25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/11/1505 : 24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/11/1007 : 19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/09/1005 : 22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/08/2605 : 07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/08/1901 : 48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/08/1604 : 48Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/07/0705 : 02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/06/1805 : 02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/05/1705 : 16Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/04/3005 : 58Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:ATRXAdhera Therapeutics Inc (PK)
2022/04/2205 : 06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ATRXAdhera Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ATRX

最近閲覧した銘柄

AMEX
BETE
Proshares Bitcoin and Et...
LSE
0A16
Vanguard S&p Small-cap 6...
EU
ALMCE
Mon Courtier Energie Gro...
AMEX
IGLD
FT Vest Gold Strategy Ta...
USOTC
NBBTF
Natural Beauty Bio Techn... (PK)
TSXV
RCZ
NASDAQ
SPRNX
Sprucegrove Internationa...
BIT
UC3REN
Unicredit Bank
TSX
TPRF
TD Active Preferred Shar...
DGFX
XRDUSDT
E-RADIX
BIT
UC8FRZ
Unicredit Bank
OKEX
IDUSDT
Space ID
LSE
13LJ
Anglo Am. 22
ASX
DRIV
BetaShares
BOV
CPLE3R
COPEL ON
BIT
UC8YK9
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有